Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ARCH

Arch Biopartners (ARCH)

Arch Biopartners Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:TSXV:ARCH
日付受信時刻ニュースソース見出しコード企業名
2020/12/1603 : 08PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ARCHTSXV:ARCHArch Biopartners Inc
2020/12/1603 : 05PR Newswire (Canada)IIROC Trading Resumption - ARCHTSXV:ARCHArch Biopartners Inc
2020/12/1601 : 37PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ARCHTSXV:ARCHArch Biopartners Inc
2020/12/1601 : 35PR Newswire (Canada)IIROC Trading Halt - ARCHTSXV:ARCHArch Biopartners Inc
2020/11/0522 : 34InvestorsHub NewsWireArch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial to Treat Complications from Covid-19TSXV:ARCHArch Biopartners Inc
2020/10/1623 : 30InvestorsHub NewsWireFirst Patient Dosed in Phase II Trial to Treat Complications in COVID-19TSXV:ARCHArch Biopartners Inc
2020/06/1700 : 05PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ARCHTSXV:ARCHArch Biopartners Inc
2020/06/1700 : 02PR Newswire (Canada)IIROC Trading Resumption - ARCHTSXV:ARCHArch Biopartners Inc
2020/06/1621 : 52PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ARCHTSXV:ARCHArch Biopartners Inc
2020/06/1621 : 50PR Newswire (Canada)IIROC Trading Halt - ARCHTSXV:ARCHArch Biopartners Inc
2020/06/0821 : 30InvestorsHub NewsWireArch Biopartners submits IND to the FDA for COVID-19 Phase II trial to prevent organ inflammation.TSXV:ARCHArch Biopartners Inc
2020/05/0821 : 03InvestorsHub NewsWireArch Biopartners Receives Health Canada Approval for COVID-19 Phase II Human TrialTSXV:ARCHArch Biopartners Inc
2020/04/2420 : 18InvestorsHub NewsWireArch Biopartners Applies to Health Canada to Conduct COVID19 Phase II Human Trial to Prevent Lung and Kidney InflammationTSXV:ARCHArch Biopartners Inc
2020/03/1800 : 53PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ARCHTSXV:ARCHArch Biopartners Inc
2020/03/1800 : 49PR Newswire (Canada)IIROC Trading Resumption - ARCHTSXV:ARCHArch Biopartners Inc
2020/03/1622 : 45PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ARCHTSXV:ARCHArch Biopartners Inc
2020/03/1622 : 42PR Newswire (Canada)IIROC Trading Halt - ARCHTSXV:ARCHArch Biopartners Inc
2018/09/2622 : 29PR Newswire (Canada)Arch Biopartners Announces Completion of GMP Manufacturing of Metablok VialsTSXV:ARCHArch Biopartners Inc
2018/08/1422 : 23PR Newswire (Canada)Arch Biopartners Engages Dalton Pharma Services for GMP Manufacturing of MetablokTSXV:ARCHArch Biopartners Inc
 Showing the most relevant articles for your search:TSXV:ARCH

最近閲覧した銘柄

Delayed Upgrade Clock